Recombinant antibody production has emerged as a potent and ground-breaking technology in biomedical research. It has completely transformed the way scientists and researchers study illnesses, create ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

Bispecific antibodies (bsAbs) are shaping the future of therapeutics, but challenges like limited throughput, low yields, and chain mispairing across diverse formats can slow progress. This white ...

You don't want to miss this! To permanently access this Infographic for free, fill out the short form below. Looking to sidestep common challenges in therapeutic antibody production, such as low ...

Bispecific antibodies (BsAbs) have emerged as a transformative class of biologics, offering dual-targeting mechanisms that enhance therapeutic efficacy across oncology, autoimmune disorders, and rare ...

Nagase Viita is building on its rich history in saccharide innovation to improve antibody production. The company provides a stable and sustainable global supply of high-quality injectable-grade ...

Typically, an antibody-drug, an anti-idiotype antibody (anti-ID Ab, see the schematic image) attaches itself to the idiotype of another antibody. An idiotype is the particular arrangement of idiotopes ...

ACTON, Mass., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”) announced that it has completed commercial-scale production of both polyclonal and ...